Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000–02 phase II study-Reference-Cited by-同舟云学术

Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000–02 phase II study

Published:2011-04 Issue:4 Volume:13 Page:281-286
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Antón Antonio, ,Barnadas Agustí,Florián Jesús,Ribelles Nuria,Lomas María,Lao Juan,González-Quintás Ana,Margelí Mireia,Paules Ana Belén,Gayo Javier,Ramos Manuel

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-011-0654-5.pdf

Reference36 articles.

1. Piccart MJ, Raymond E, Aapro M et al (1995) Cytotoxic agents with activity in breast cancer patients previously exposed to anthracyclines: current status and future prospects. Eur J Cancer 31A[Suppl 7]:S1–10

2. Esteva FJ, Valero V, Pusztai L et al (2001) Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 6:133–146

3. Seidman AD (2006) Systemic treatment of breast cancer. Two decades of progress. Oncology (Williston Park) 20:983–990; discussion 991–992, 997–998

4. Gralow JR (2005) Optimizing the treatment of metastatic breast cancer. Breast Cancer Res Treat 89[Suppl 1]:S9–S15

5. Abu-Khalaf MM, Harris L (2009) Anthracycline-induced cardiotoxicity: risk assessment and management. Oncology (Williston Park) 23:239, 244, 252

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards personalized medicine of colorectal cancer;Critical Reviews in Oncology/Hematology;2017-10